Loading...
Loading...
Pharming Group N.V.
Pharming Group N.V.. Spoken Alpha tracks PHAR's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PHAR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PHAR.
curl https://api.spokenalpha.com/v1/companies/PHAR| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.63 | $3.21 | +13.2% | +2.2% | +3.5% |
| Q4 FY2026 | $3.99 | $3.28 | +21.6% | +7.3% | +8.0% |
| Q3 FY2026 | $4.09 | $3.37 | +21.4% | +9.2% | +11.1% |
| Q2 FY2026 | $3.85 | $3.26 | +18.0% | -1.6% | +0.2% |
| Q1 FY2025 | $3.78 | $3.40 | +11.3% | -1.3% | 0.0% |
| Q4 FY2025 | $3.84 | $3.28 | +17.2% | +4.9% | +6.4% |
| Q3 FY2025 | $4.02 | $3.38 | +19.0% | +3.4% | +1.9% |
| Q2 FY2025 | $4.03 | $3.36 | +20.0% | +6.4% | +5.2% |
| Q1 FY2024 | $4.41 | $3.57 | +23.4% | +6.7% | +6.2% |
| Q4 FY2024 | $4.03 | $3.45 | +16.8% | -1.1% | -3.6% |